News and Announcements
Prescient Therapeutics Investor Presentation April 2016
- Published April 13, 2016 11:52AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
13th April 2016, ASX Announcement
Investment Summary: Why all the excitement about AML?
- Acute Myeloid Leukemia (AML) is an area of substantial unmet medical need.
– One of the worst survival rates of all cancers
– Standard of care unchanged for 40 years - A disease of intense interest for clinicans, pharma companies and investors
- Celator Pharmaceuticals (NASDAQ: CPXX) showed what can happen when enhancing the standard of care in AML
– Market cap recently surged from small cap to $780M
-Dr Jeff Lancet was the Principal Investigator on CPXX’s ground-breaking trial - PTX has successful Phase 1 trial in AML (conducted at Moffitt and MD Anderson)
To view the full article please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
